This AOP is licensed under the BY-SA license. This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.

AOP: 324

Title

A descriptive phrase which references both the Molecular Initiating Event and Adverse Outcome.It should take the form “MIE leading to AO”. For example, “Aromatase inhibition leading to reproductive dysfunction” where Aromatase inhibition is the MIE and reproductive dysfunction the AO. In cases where the MIE is unknown or undefined, the earliest known KE in the chain (i.e., furthest upstream) should be used in lieu of the MIE and it should be made clear that the stated event is a KE and not the MIE.  More help

Excessive reactive oxygen species leading to growth inhibition via uncoupling of oxidative phosphorylation and cell death

Short name
A name that succinctly summarises the information from the title. This name should not exceed 90 characters. More help
ROS leading to growth inhibition via OXPHOS uncoupling and cell death
The current version of the Developer's Handbook will be automatically populated into the Handbook Version field when a new AOP page is created.Authors have the option to switch to a newer (but not older) Handbook version any time thereafter. More help
Handbook Version v2.0

Graphical Representation

A graphical representation of the AOP.This graphic should list all KEs in sequence, including the MIE (if known) and AO, and the pair-wise relationships (links or KERs) between those KEs. More help
Click to download graphical representation template Explore AOP in a Third Party Tool

Authors

The names and affiliations of the individual(s)/organisation(s) that created/developed the AOP. More help

You Songa

a Norwegian Institute for Water Research (NIVA), Økernveien 94, NO-0579 Oslo, Norway

Point of Contact

The user responsible for managing the AOP entry in the AOP-KB and controlling write access to the page by defining the contributors as described in the next section.   More help

Contributors

Users with write access to the AOP page.  Entries in this field are controlled by the Point of Contact. More help
  • You Song

Coaches

This field is used to identify coaches who supported the development of the AOP.Each coach selected must be a registered author. More help
  • Shihori Tanabe

OECD Information Table

Provides users with information concerning how actively the AOP page is being developed and whether it is part of the OECD Workplan and has been reviewed and/or endorsed. OECD Project: Assigned upon acceptance onto OECD workplan. This project ID is managed and updated (if needed) by the OECD. OECD Status: For AOPs included on the OECD workplan, ‘OECD status’ tracks the level of review/endorsement of the AOP . This designation is managed and updated by the OECD. Journal-format Article: The OECD is developing co-operation with Scientific Journals for the review and publication of AOPs, via the signature of a Memorandum of Understanding. When the scientific review of an AOP is conducted by these Journals, the journal review panel will review the content of the Wiki. In addition, the Journal may ask the AOP authors to develop a separate manuscript (i.e. Journal Format Article) using a format determined by the Journal for Journal publication. In that case, the journal review panel will be required to review both the Wiki content and the Journal Format Article. The Journal will publish the AOP reviewed through the Journal Format Article. OECD iLibrary published version: OECD iLibrary is the online library of the OECD. The version of the AOP that is published there has been endorsed by the OECD. The purpose of publication on iLibrary is to provide a stable version over time, i.e. the version which has been reviewed and revised based on the outcome of the review. AOPs are viewed as living documents and may continue to evolve on the AOP-Wiki after their OECD endorsement and publication.   More help
OECD Project # OECD Status Reviewer's Reports Journal-format Article OECD iLibrary Published Version
This AOP was last modified on September 12, 2025 02:28

Revision dates for related pages

Page Revision Date/Time
Increase, Reactive oxygen species June 12, 2025 01:27
Increase, Oxidative Stress February 11, 2026 07:05
Decrease, Coupling of oxidative phosphorylation November 07, 2025 05:15
Decrease, Adenosine triphosphate pool June 14, 2021 13:40
Increase, Cell injury/death May 27, 2024 07:23
Decrease, Growth July 06, 2022 07:36
Increase, ROS leads to Increase, Oxidative Stress August 02, 2024 15:40
Increase, Oxidative Stress leads to Decrease, Coupling of OXPHOS August 21, 2025 08:44
Decrease, Coupling of OXPHOS leads to Decrease, ATP pool July 06, 2022 07:39
Decrease, ATP pool leads to Cell injury/death September 27, 2022 13:24
Cell injury/death leads to Decrease, Growth September 27, 2022 13:22
Heavy metals (cadmium, lead, copper, iron, nickel) October 25, 2021 03:21

Abstract

A concise and informative summation of the AOP under development that can stand-alone from the AOP page. The aim is to capture the highlights of the AOP and its potential scientific and regulatory relevance. More help

Reactive oxygen species (ROS) are by-products of normal cellular metabolism, but excessive ROS production can lead to oxidative stress and widespread macromolecular damage. This AOP network (AOPN) describes multiple interconnected pathways by which increased ROS can impair organismal growth. The molecular initiating event is an increase in ROS, which triggers oxidative damage to lipids, proteins, and DNA. These molecular changes converge on mitochondrial dysfunction through decreased coupling of oxidative phosphorylation and fatty acid β-oxidation, resulting in ATP depletion. In parallel, oxidative DNA damage and insufficient repair lead to DNA strand breaks and cell cycle disruption. Together, these pathways decrease cell proliferation and cell growth, promote cell injury and death, and ultimately reduce growth at the organism level. By integrating several parallel and converging biological events, this AOPN reflects the complexity of oxidative stress outcomes. It provides a mechanistic framework of high regulatory relevance, as oxidative stress is a common mode of action for many environmental contaminants. This AOPN supports the development of predictive in vitro assays, read-across strategies, and refined approaches for chemical safety and ecological risk assessment.

AOP Development Strategy

Context

Used to provide background information for AOP reviewers and users that is considered helpful in understanding the biology underlying the AOP and the motivation for its development.The background should NOT provide an overview of the AOP, its KEs or KERs, which are captured in more detail below. More help

Reactive oxygen species (ROS) play a dual role in biology, functioning as essential signaling molecules under physiological conditions but becoming harmful when produced in excess. Imbalance between ROS generation and antioxidant defenses, commonly referred to as oxidative stress, has been linked to a wide spectrum of toxicological outcomes in both human health and environmental species. Growth impairment is of particular regulatory concern because it represents a sensitive and integrative endpoint that reflects energy status, cellular function, and organismal fitness. AOP networks (AOPNs) are especially relevant for oxidative stress, as ROS-mediated damage affects multiple cellular targets in parallel, leading to complex and interacting pathways of toxicity. Understanding these connections is critical for developing predictive toxicology tools that can account for chemical diversity and species-specific responses. The development of this AOPN is motivated by the need to capture the mechanistic complexity of oxidative stress and its consequences for growth, and to provide a transparent, structured framework that can be applied in regulatory decision-making. This AOPN is intended to support chemical risk assessment, ecological impact evaluation, and the design of alternative test methods that reduce reliance on animal testing.

Strategy

Provides a description of the approaches to the identification, screening and quality assessment of the data relevant to identification of the key events and key event relationships included in the AOP or AOP network.This information is important as a basis to support the objective/envisaged application of the AOP by the regulatory community and to facilitate the reuse of its components.  Suggested content includes a rationale for and description of the scope and focus of the data search and identification strategy/ies including the nature of preliminary scoping and/or expert input, the overall literature screening strategy and more focused literature surveys to identify additional information (including e.g., key search terms, databases and time period searched, any tools used). More help

The development of this AOP network (AOPN) followed a structured approach to identify, screen, and evaluate the evidence supporting the key events (KEs) and key event relationships (KERs). The strategy was designed to ensure transparency, reproducibility, and reusability of the information for regulatory applications.

The scope of the literature search was defined by the biological problem of interest: the role of reactive oxygen species (ROS) in driving oxidative stress and its downstream consequences on growth. The focus was on conserved cellular processes relevant across species (e.g., mitochondrial function, DNA damage and repair, cell proliferation, energy metabolism) and their contribution to growth impairment at the organism level.

An initial scoping review was performed to map the key domains of biology where ROS has well-established toxicological impacts. Expert input from oxidative stress and ecotoxicology research was used to prioritize candidate KEs and to identify relevant biomarkers and assays. This scoping step ensured that the AOPN captured both canonical pathways (e.g., oxidative phosphorylation) and parallel events (e.g., DNA damage responses).

A tiered literature search strategy was applied:

  • Primary screening: Broad keyword searches in PubMed, Web of Science, and Scopus using combinations of terms such as reactive oxygen species, oxidative stress, mitochondrial dysfunction, oxidative phosphorylation, DNA damage, cell cycle, cell proliferation, growth impairment. Searches covered the period from 1990–2023 to include both foundational and recent advances.
  • Focused surveys: Targeted searches for specific KERs, e.g., oxidative stress AND mitochondrial ATP depletion, ROS AND DNA strand breaks, oxidative stress AND growth inhibition (fish OR mammal).
  • Regulatory and guidance documents: Additional screening of OECD publications, test guidelines (e.g., TG 249), and mechanistic toxicology reviews to capture regulatory relevance and assay development efforts.
  • Automated tools: AOP-help tools including AOP-helpFinder and AOP-BOT were employed to systematically mine literature, extract relevant key event associations, and ensure alignment with existing AOPs in the AOP-Wiki knowledgebase. These tools provided cross-validation of manually identified KEs/KERs and highlighted potential network linkages.

Abstracts were reviewed for relevance, with exclusion of studies not addressing mechanistic links between ROS and cellular/organismal growth outcomes. Full-text evaluation was conducted for studies meeting inclusion criteria. Where available, systematic reviews and meta-analyses were prioritized.

The weight-of-evidence (WoE) approach recommended in the OECD Users’ Handbook Supplement was applied. This included evaluation of:

  • Biological plausibility of each KE and KER.
  • Essentiality of events, supported by experimental manipulation studies.
  • Empirical support, assessed through dose-response, temporal, and incidence concordance.
  • Quantitative understanding, considering thresholds and cross-species extrapolation.

The combined manual and automated strategy ensured that the AOPN is built upon a comprehensive and critically assessed evidence base. Use of tools such as AOP-helpFinder and AOP-BOT enhanced transparency, supported efficient literature mining, and facilitated re-use of individual KEs, KERs, and supporting evidence in future AOPs and AOP networks.

Summary of the AOP

This section is for information that describes the overall AOP.The information described in section 1 is entered on the upper portion of an AOP page within the AOP-Wiki. This is where some background information may be provided, the structure of the AOP is described, and the KEs and KERs are listed. More help

Events:

Molecular Initiating Events (MIE)
An MIE is a specialised KE that represents the beginning (point of interaction between a prototypical stressor and the biological system) of an AOP. More help
Key Events (KE)
A measurable event within a specific biological level of organisation. More help
Adverse Outcomes (AO)
An AO is a specialized KE that represents the end (an adverse outcome of regulatory significance) of an AOP. More help
Type Event ID Title Short name
MIE 1115 Increase, Reactive oxygen species Increase, ROS
KE 1392 Increase, Oxidative Stress Increase, Oxidative Stress
KE 1446 Decrease, Coupling of oxidative phosphorylation Decrease, Coupling of OXPHOS
KE 1771 Decrease, Adenosine triphosphate pool Decrease, ATP pool
KE 55 Increase, Cell injury/death Cell injury/death
AO 1521 Decrease, Growth Decrease, Growth

Relationships Between Two Key Events (Including MIEs and AOs)

This table summarizes all of the KERs of the AOP and is populated in the AOP-Wiki as KERs are added to the AOP.Each table entry acts as a link to the individual KER description page. More help

Network View

This network graphic is automatically generated based on the information provided in the MIE(s), KEs, AO(s), KERs and Weight of Evidence (WoE) summary tables. The width of the edges representing the KERs is determined by its WoE confidence level, with thicker lines representing higher degrees of confidence. This network view also shows which KEs are shared with other AOPs. More help

Prototypical Stressors

A structured data field that can be used to identify one or more “prototypical” stressors that act through this AOP. Prototypical stressors are stressors for which responses at multiple key events have been well documented. More help

Life Stage Applicability

The life stage for which the AOP is known to be applicable. More help
Life stage Evidence
Not Otherwise Specified

Taxonomic Applicability

Latin or common names of a species or broader taxonomic grouping (e.g., class, order, family) can be selected.In many cases, individual species identified in these structured fields will be those for which the strongest evidence used in constructing the AOP was available. More help
Term Scientific Term Evidence Link
fish fish NCBI

Sex Applicability

The sex for which the AOP is known to be applicable. More help
Sex Evidence
Unspecific

Overall Assessment of the AOP

Addressess the relevant biological domain of applicability (i.e., in terms of taxa, sex, life stage, etc.) and Weight of Evidence (WoE) for the overall AOP as a basis to consider appropriate regulatory application (e.g., priority setting, testing strategies or risk assessment). More help

The biological relevance of this AOP network (AOPN) is supported by the highly conserved nature of oxidative stress mechanisms across taxa. ROS production, antioxidant defenses, mitochondrial function, and DNA damage responses are core processes in nearly all aerobic organisms, providing strong confidence in the applicability of this AOPN to both human health and ecological species. The pathway is not sex-specific, and although subtle sex-dependent differences in antioxidant capacity have been reported, the fundamental mechanisms apply broadly to males and females. Growth impairment is relevant throughout the life cycle, but early developmental stages are especially sensitive due to high energy demands and rapid cellular proliferation.

The weight of evidence (WoE) for the overall AOPN is robust. There is strong biological plausibility linking the molecular initiating event (ROS increase) to the adverse outcome (reduced growth), supported by decades of mechanistic toxicology research. Essentiality of key events is well established, as mitochondrial dysfunction, oxidative DNA damage, and disruption of cell proliferation are widely recognized as causal determinants of growth impairment. Empirical support across multiple taxa demonstrates consistent dose–response, temporal, and incidence concordance among key events. While quantitative understanding is still being refined, especially for cross-species extrapolation and thresholds of effect, the existing evidence base provides a solid foundation for application.

From a regulatory perspective, this AOPN offers value in several contexts. It can support priority setting by identifying chemicals likely to cause growth impairment through oxidative stress. It is also suitable for guiding integrated testing strategies, particularly in the development and application of in vitro assays and non-animal methods. Finally, the AOPN contributes to risk assessment by providing a mechanistic framework that links molecular perturbations to ecologically and toxicologically relevant outcomes. Overall, this AOPN provides a scientifically credible and broadly applicable basis for regulatory decision-making.

Domain of Applicability

Addressess the relevant biological domain(s) of applicability in terms of sex, life-stage, taxa, and other aspects of biological context. More help

This AOP network (AOPN) is broadly applicable across taxa due to the conserved nature of oxidative stress biology. The generation of reactive oxygen species (ROS), antioxidant defense mechanisms, and mitochondrial oxidative phosphorylation are fundamental processes present in nearly all aerobic organisms. Likewise, cellular responses to oxidative DNA damage, disrupted energy metabolism, and impaired cell proliferation are highly conserved from invertebrates to vertebrates, including humans.

  • Taxonomic applicability: Evidence supports relevance across diverse species, including fish, invertebrates, and mammals. The core biological mechanisms underlying ROS production and mitochondrial function are conserved across metazoans.

  • Life stage applicability: Growth is a critical endpoint at all life stages, but early developmental stages (embryonic, larval, juvenile) are particularly sensitive to oxidative stress due to high energy demands and rapid cell proliferation.

  • Sex applicability: The pathway is not sex-specific. While sex-dependent differences in antioxidant capacity may exist, the fundamental mechanisms described in this AOPN apply to both males and females.

Overall, this AOPN has broad applicability in both human health and environmental contexts. Its strength lies in capturing conserved biological mechanisms of oxidative stress, while allowing for refinement and species-specific considerations in regulatory use.

Essentiality of the Key Events

The essentiality of KEs can only be assessed relative to the impact of manipulation of a given KE (e.g., experimentally blocking or exacerbating the event) on the downstream sequence of KEs defined for the AOP. Consequently, evidence supporting essentiality is assembled on the AOP page, rather than on the independent KE pages that are meant to stand-alone as modular units without reference to other KEs in the sequence. The nature of experimental evidence that is relevant to assessing essentiality relates to the impact on downstream KEs and the AO if upstream KEs are prevented or modified. This includes: Direct evidence: directly measured experimental support that blocking or preventing a KE prevents or impacts downstream KEs in the pathway in the expected fashion. Indirect evidence: evidence that modulation or attenuation in the magnitude of impact on a specific KE (increased effect or decreased effect) is associated with corresponding changes (increases or decreases) in the magnitude or frequency of one or more downstream KEs. More help

Evidence Assessment

Addressess the biological plausibility, empirical support, and quantitative understanding from each KER in an AOP. More help

Known Modulating Factors

Modulating factors (MFs) may alter the shape of the response-response function that describes the quantitative relationship between two KES, thus having an impact on the progression of the pathway or the severity of the AO.The evidence supporting the influence of various modulating factors is assembled within the individual KERs. More help
Modulating Factor (MF) Influence or Outcome KER(s) involved
     

Quantitative Understanding

Optional field to provide quantitative weight of evidence descriptors.  More help

Considerations for Potential Applications of the AOP (optional)

Addressess potential applications of an AOP to support regulatory decision-making.This may include, for example, possible utility for test guideline development or refinement, development of integrated testing and assessment approaches, development of (Q)SARs / or chemical profilers to facilitate the grouping of chemicals for subsequent read-across, screening level hazard assessments or even risk assessment. More help

This AOP network (AOPN) has broad potential to inform regulatory decision-making, given the central role of oxidative stress in chemical toxicity and the ecological and human health relevance of growth impairment as an endpoint. Several areas of application can be envisaged:

  • Test guideline development and refinement: The mechanistic framework provides a basis for designing and validating in vitro assays that capture upstream key events such as ROS production, mitochondrial dysfunction, or DNA damage. Relevant OECD Test Guidelines (e.g., TG 249: Fish Cell Line Acute Toxicity) already use cell-based measures of biomass/growth inhibition and could be refined to incorporate oxidative stress endpoints. In vitro assays developed in this context could complement or partially replace traditional apical growth studies, reducing reliance on animal testing.

  • Integrated testing and assessment approaches (IATA): The AOPN can serve as a scaffold for IATA frameworks promoted by the OECD, integrating data streams from in vitro, in silico, and omics technologies. By linking early molecular events to organismal growth impairment, it supports transparent weight-of-evidence evaluations and structured regulatory decision-making.

  • Chemical grouping and read-across: Because oxidative stress is a common mode of action for many structurally diverse chemicals, the AOPN can facilitate grouping and category formation. Coupled with tools such as the OECD QSAR Toolbox, chemical profilers, or structural alerts for ROS-inducing potential, the AOPN can support read-across approaches for untested substances.

  • Screening-level hazard assessment: The AOPN provides a mechanistic rationale for prioritizing chemicals that induce oxidative stress for further evaluation. Screening batteries could include biomarkers of oxidative stress or intermediate key events (e.g., mitochondrial dysfunction, DNA damage) to identify potential growth-impairing agents at early stages.

  • Risk assessment: By linking molecular initiating events to an ecologically and toxicologically relevant adverse outcome, the AOPN supports extrapolation from mechanistic data to population- or organism-level consequences. This mechanistic anchoring strengthens confidence in risk assessments and enhances their predictive power for both human health and environmental protection.

Overall, this AOPN contributes directly to OECD initiatives on mechanistic risk assessment, development of non-animal methods, and harmonization of predictive toxicology tools, thereby increasing its scientific and regulatory utility.

References

List of the literature that was cited for this AOP. More help